z-logo
open-access-imgOpen Access
Intestinal titres of anti‐tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten‐free diet duration in coeliac disease
Author(s) -
Tosco A.,
Auricchio R.,
Aitoro R.,
Ponticelli D.,
Primario M.,
Miele E.,
Rotondi Aufiero V.,
Discepolo V.,
Greco L.,
Troncone R.,
Maglio M.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12366
Subject(s) - tissue transglutaminase , antibody , gliadin , gluten free , immunology , coeliac disease , gastroenterology , intestinal mucosa , medicine , biology , gluten , disease , enzyme , pathology , biochemistry
Summary It has always been known that anti‐tissue transglutaminase 2 (anti‐ TG 2) antibodies are produced in the small intestine. Their serum titres correlate with mucosal damage degree and decrease on a gluten‐free diet ( GFD ). We aimed to correlate intestinal anti‐ TG 2 antibodies levels with degree of mucosal damage and GFD duration. Thirty‐four active, 71 potential and 24 CD patients on GFD for at least 2 years were enrolled. Anti‐ TG 2 deposits were detected in intestinal biopsies by double immunofluorescence. Biopsies were cultured for 24 h with medium, and with gliadin peptic tryptic digest ( PTG ) or A‐gliadin peptide 31–43 ( P 31‐43). Anti‐ TG 2 antibodies secreted into supernatants were measured by enzyme‐linked immunosorbent assay ( ELISA) . All active CD patients secreted high titres of anti‐ TG 2 antibodies into culture medium that increased with the worsening of mucosal injury (Spearman's r  = 0·71; P  < 0·0001). Seventy of 71 potential CD patients and 15 of 24 treated CD patients secreted low titres of anti‐ TG 2 antibodies into supernatants, eight of nine negative treated patients being on GFD for more than 10 years. An inverse correlation between antibody titres and duration of GFD was found, (Spearman's r  = −0·52; P  < 0·01). All active, 53 of 71 potential and six of 24 treated, CD patients showed anti‐ TG 2 mucosal deposits. Five of six positive treated CD patients had been on GFD for fewer than 6 years and were also positive for secreted anti‐ TG 2. In treated patients, PTG /P31‐43 was not able to induce secretion of anti‐ TG 2 antibodies into culture medium. Measurement of anti‐ TG 2 antibodies in biopsy supernatants proved to be more sensitive than detection by immunofluorescence to reveal their intestinal production. Intestinal anti TG 2 antibodies titres correlated positively with the degree of mucosal damage and inversely with the duration of GFD .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom